PubRank

Alexander W Clowes

Author PubWeight™ 52.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 2006 3.38
2 Smooth muscle cell plasticity: fact or fiction? Circ Res 2012 2.18
3 Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss. Circulation 2008 1.80
4 Vasodilator-stimulated phosphoprotein regulates proliferation and growth inhibition by nitric oxide in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2004 1.31
5 Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 2006 1.30
6 Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 2005 1.26
7 Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res 2005 1.24
8 Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res 2004 1.23
9 Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ Res 2002 1.21
10 Images in cardiovascular medicine. Serial high-spatial-resolution, multisequence magnetic resonance imaging studies identify fibrous cap rupture and penetrating ulcer into carotid atherosclerotic plaque. Circulation 2006 1.13
11 Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arterioscler Thromb Vasc Biol 2011 1.11
12 Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia. J Vasc Surg 2007 1.09
13 Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg 2007 1.07
14 Thrombin- and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res 2003 1.05
15 Syndecan-4 is required for thrombin-induced migration and proliferation in human vascular smooth muscle cells. J Biol Chem 2005 1.04
16 Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg 2006 1.03
17 Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. J Vasc Surg 2003 1.03
18 The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients. J Vasc Surg 2003 1.02
19 Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding. Diabetes 2011 1.01
20 Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis. J Vasc Surg 2002 1.00
21 Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg 2005 0.98
22 Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury. Am J Pathol 2008 0.96
23 Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial. J Vasc Surg 2007 0.96
24 Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells. Arterioscler Thromb Vasc Biol 2002 0.94
25 Increased plasmin and serine proteinase activity during flow-induced intimal atrophy in baboon PTFE grafts. Arterioscler Thromb Vasc Biol 2002 0.94
26 Bone morphogenetic protein 4: potential regulator of shear stress-induced graft neointimal atrophy. J Vasc Surg 2006 0.93
27 Twentieth anniversary of American Vascular Association/Lifeline Foundation: a celebration. J Vasc Surg 2008 0.93
28 Induction of vascular atrophy as a novel approach to treating restenosis. A review. J Vasc Surg 2007 0.92
29 VASP increases hepatic fatty acid oxidation by activating AMPK in mice. Diabetes 2013 0.92
30 Reviving the vascular surgeon-scientist: an interim assessment of the jointly sponsored Lifeline Foundation/National Heart, Lung, and Blood Institute William J. von Liebig Mentored Clinical Scientist Development (K08) Program. J Vasc Surg 2007 0.91
31 Concomitant blockade of platelet-derived growth factor receptors alpha and beta induces intimal atrophy in baboon PTFE grafts. J Vasc Surg 2004 0.91
32 Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries. J Vasc Surg 2004 0.90
33 Accumulation and loss of extracellular matrix during shear stress-mediated intimal growth and regression in baboon vascular grafts. J Histochem Cytochem 2005 0.90
34 Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg 2006 0.90
35 Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis. J Vasc Surg 2009 0.88
36 MMP-9 regulates both positively and negatively collagen gel contraction: a nonproteolytic function of MMP-9. Cardiovasc Res 2004 0.88
37 Cell death-associated ADAMTS4 and versican degradation in vascular tissue. J Histochem Cytochem 2009 0.87
38 Vasospasm as a cause for claudication in athletes with external iliac artery endofibrosis. J Vasc Surg 2013 0.86
39 Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia. Arterioscler Thromb Vasc Biol 2009 0.84
40 VASP phosphorylation at serine239 regulates the effects of NO on smooth muscle cell invasion and contraction of collagen. J Cell Physiol 2010 0.82
41 A link between smooth muscle cell death and extracellular matrix degradation during vascular atrophy. J Vasc Surg 2011 0.81
42 Interleukin-1beta inhibits PDGF-BB-induced migration by cooperating with PDGF-BB to induce cyclooxygenase-2 expression in baboon aortic smooth muscle cells. J Vasc Surg 2004 0.80
43 Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases. Arterioscler Thromb Vasc Biol 2004 0.79
44 Effect of an anti-PDGF-beta-receptor-blocking antibody on restenosis in patients undergoing elective stent placement. Int J Cardiovasc Intervent 2003 0.78
45 Dacron patch infection after carotid endarterectomy: case report and review of the literature. Ann Vasc Surg 2006 0.78
46 Low levels of a natural IgM antibody are associated with vein graft stenosis and failure. J Vasc Surg 2013 0.78
47 Arterial injury repair in nonhuman primates-the role of PDGF receptor-beta. J Surg Res 2004 0.77
48 Effects of external wrapping and increased blood flow on atrophy of the baboon iliac artery. J Vasc Surg 2008 0.77
49 Efficient gene transfer and durable transgene expression in grafted rabbit veins. Hum Gene Ther 2015 0.76
50 Inhibition of PDGF-B induction and cell growth by syndecan-1 involves the ubiquitin and SUMO-1 ligase, Topors. PLoS One 2012 0.75